The Renal Care segment focuses on providing life-sustaining dialysis therapies and related products for patients with kidney failure. This includes peritoneal dialysis (PD) and hemodialysis (HD) treatments, along with associated equipment, supplies, and services. Research and development efforts concentrate on improving dialysis efficiency, patient comfort, and home dialysis options. Technologies include advanced dialysis machines, automated PD cyclers, and connected health platforms for remote patient monitoring. The segment addresses the needs of patients with chronic kidney disease and acute kidney injury, aiming to improve their quality of life and reduce hospitalizations. Market positioning emphasizes innovation, patient-centric care, and global reach. Future opportunities lie in expanding home dialysis programs, developing new dialysis modalities, and leveraging digital health solutions. Regulatory and clinical aspects involve rigorous testing and approval processes to ensure patient safety and efficacy. Partnerships with healthcare providers and patient advocacy groups are crucial for delivering comprehensive care.

This segment encompasses intravenous (IV) therapies, infusion pumps, administration sets, and drug reconstitution devices. Research and development efforts focus on enhancing the safety, accuracy, and efficiency of medication delivery. Technologies include smart infusion pumps with integrated drug libraries, pre-mixed IV solutions, and closed-system transfer devices to minimize medication errors and healthcare-associated infections. The segment serves hospitals, clinics, and home healthcare settings, addressing the needs of patients requiring IV medications, fluids, and nutrition. Market positioning emphasizes patient safety, clinical effectiveness, and technological innovation. Future opportunities include expanding the use of connected health solutions for remote monitoring and medication management. Regulatory and clinical aspects involve compliance with stringent standards for device safety and drug compatibility. Partnerships with pharmaceutical companies and healthcare providers are essential for delivering comprehensive medication management solutions.

The Advanced Surgery segment focuses on developing and providing products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention. Research and development activities concentrate on creating innovative surgical tools and materials that improve surgical outcomes and reduce complications. Technologies include hemostatic agents, surgical sealants, and anti-adhesion products. The segment serves surgeons and operating room staff in various surgical specialties, addressing the needs of patients undergoing surgical procedures. Market positioning emphasizes innovation, clinical effectiveness, and ease of use. Future opportunities include expanding the portfolio of advanced surgical products and developing new technologies for minimally invasive surgery. Regulatory and clinical aspects involve rigorous testing and approval processes to ensure product safety and efficacy. Partnerships with surgical societies and key opinion leaders are crucial for driving adoption and improving surgical practices.